ChartRow logo
Data provided bySource: Twelve Data
PeersVTRAHROHIDOCLINPM
Share this page

WELL financial statements

The full income statement, balance sheet, and cash-flow statement for Welltower Inc. (WELL), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +18.7%10Y CAGR +10.9%YoY +38.4%
$13.8B TTM$3.7B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Gross profit

YoY +1.6%
— FY25— Q3 '26
FY17FY18FY19FY20FY21FY22FY23FY24FY25
Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR −0.9%10Y CAGR +0.6%YoY +41.4%
$1.7B TTM$396.6M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR −9.8%10Y CAGR −5.1%YoY +31.7%
$2.28 TTM$0.54 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y CAGR +16.1%10Y CAGR +7.6%YoY +16.9%
$3.3B TTM$1B Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR +33.8%10Y CAGR −11.4%YoY +32.3%
$1.3B TTM$348M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +10.3%10Y n/mYoY +10.0%
$2.1B TTM$655.1M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y +62.8%10Y +94.5%YoY +10.1%
732.4M TTM754.9M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Dividend per share

5Y CAGR +0.9%10Y CAGR −1.6%YoY +14.9%
$2.96 TTM$0.85 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Every WELL chart on Trends →

Shares outstanding (point-in-time)

2024-09 622.7M2024-12 641.3M2025-03 654.0M2025-06 668.8M2025-09 686.3M2025-12 697.8M2026-03 705.9M2026-06 720.7M2026-09 733.6M+17.8% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
10.8B+35.6%7.99B+20.4%6.64B+13.3%5.86B+23.6%4.74B+3.0%
Lease income1.97B+25.3%1.57B+0.9%1.56B+7.2%1.45B+5.6%1.37B-4.8%
Cost of revenue6.49B+34.3%4.83B+22.4%3.95B+10.9%3.56B+28.3%2.77B+6.8%
Selling, general & administrative1.75B+642.5%235M+31.5%179M+19.1%150M+18.7%127M-1.3%
Provision for credit losses
————7.27M-92.3%
Interest expense——608M+14.8%530M+8.1%490M-4.8%
Other non-operating income——-108M-6.6%-102M-143.6%-41.7M+40.7%
Equity-method income-14.3M-2782.5%-496K+99.1%-53.4M-151.0%-21.3M+7.2%-22.9M-183.7%
Pre-tax income—524M+49.8%350M+102.3%173M+1.4%171M+641.2%
Income tax-7.12M-363.6%2.70M-57.6%6.36M-12.2%7.25M-16.8%8.71M-12.6%
937M-1.6%952M+179.8%340M+140.8%141M-58.0%336M-65.7%
Net income to non-controlling interest25.0M+18.0%21.2M+17.4%18.0M-6.8%19.4M-49.5%38.3M-36.1%
Net income to common937M-1.6%952M+179.8%340M+140.8%141M-58.0%336M-65.7%
$1.39-11.5%$1.57+137.9%$0.66+120.0%$0.30-61.5%$0.78-66.5%
EPS (basic)$1.41-10.8%$1.58+139.4%$0.66+112.9%$0.31-60.8%$0.79-66.5%
Weighted-avg shares (basic)666M+10.4%603M+16.9%516M+11.6%462M+8.8%425M+2.3%
Weighted-avg shares (diluted)680M+11.6%609M+17.4%519M+11.5%465M+9.0%427M+2.3%
Dividends per share$2.82+10.2%$2.56+4.9%$2.44+0.0%$2.44+0.0%$2.44-9.6%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Cash & equivalents5.03B+43.5%3.51B+75.9%1.99B+215.6%632M+134.6%269M-82.6%
67.3B+31.9%51.0B+16.0%44.0B+16.1%37.9B+8.5%34.9B+7.5%
Goodwill346M+132.1%149M+118.4%68.3M+0.0%68.3M+0.0%68.3M+0.0%
Intangible assets909M+36.5%666M+29.4%515M+11.6%461M-8.3%503M+56.1%
Short-term & current debt0.000.000.000.00-100.0%325M
24.1B+30.5%18.5B+4.7%17.6B+6.9%16.5B+3.7%15.9B+4.3%
Long-term debt19.2B+23.9%15.5B-1.5%15.7B+8.2%14.5B+5.4%13.8B+0.1%
Operating lease liability (total)1.64B+42.8%1.15B+278.9%304M+0.4%302M-30.4%434M+39.6%
Finance lease liability (total)540M+400.0%108M+35.6%79.7M-29.8%113M+1.6%112M+4.3%
42.1B+31.8%32.0B+25.8%25.4B+25.2%20.3B+15.1%17.6B+10.4%
Common stock697M+9.4%637M+12.6%566M+15.0%492M+9.7%449M+7.1%
Additional paid-in capital50.9B+27.2%40.0B+22.2%32.7B+22.4%26.7B+15.6%23.1B+11.1%
Retained earnings11.0B+9.3%10.1B+10.4%9.15B+3.9%8.80B+1.6%8.66B+4.0%
Treasury stock14.4M-87.4%114M+2.3%112M+0.5%111M+3.0%108M+3.1%
Accumulated other comprehensive income-288M+20.1%-360M-120.5%-163M-36.3%-120M+1.3%-121M+18.3%
Non-controlling interest810M+125.0%360M-46.8%677M-5.3%715M-25.6%961M+5.7%
Total equity incl. non-controlling42.9B+32.9%32.3B+23.9%26.1B+24.1%21.0B+13.0%18.6B+10.2%
Total liabilities & equity67.3B+31.9%51.0B+16.0%44.0B+16.1%37.9B+8.5%34.9B+7.5%
Common shares issued697M+9.4%637M+12.6%566M+15.0%492M+9.6%449M+7.1%
Common shares outstanding697M+9.6%635M+12.6%564M+15.0%491M+9.7%447M+7.1%
Shares outstanding (cover)698M+8.8%641M+12.7%569M+15.9%491M+9.7%447M+7.2%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
2.88B+27.7%2.26B+40.9%1.60B+20.6%1.33B+4.2%1.28B-6.6%
Depreciation & amortization2.08B+27.7%1.63B+16.5%1.40B+6.9%1.31B+26.3%1.04B-0.1%
Share-based compensation1.56B+1953.2%75.8M+103.8%37.2M+42.3%26.1M+46.8%17.8M-37.1%
Deferred income taxes-49.6M-661.4%-6.52M-163.2%-2.48M+77.6%-11.0M-643.1%-1.49M-6.9%
-10.5B-90.6%-5.51B+3.4%-5.71B-54.1%-3.70B+18.0%-4.52B-292.4%
Capital expenditure1.05B+22.5%858M+65.7%518M+8.8%476M+68.4%283M+15.3%
Free cash flow1.83B+30.9%1.40B+29.0%1.08B+27.1%853M-14.1%993M-11.3%
Acquisitions
————0.00
Proceeds from sale of PP&E5.66B+1581.4%337M+247.9%96.7M-51.5%199M-81.4%1.07B-75.1%
Other investing activities73.8M+20.9%61.0M-39.1%100M+1.7%98.5M+270.2%26.6M+444.2%
9.00B+83.5%4.91B-10.0%5.45B+97.3%2.76B+76.1%1.57B+175.3%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued
————2.35B+294.4%
Common stock repurchased0.000.000.000.000.00-100.0%
Dividends paid1.88B+21.5%1.55B+22.6%1.26B+11.4%1.13B+9.2%1.04B-7.4%
Other financing activities-14.4M+78.0%-65.3M-397.6%-13.1M-74.3%-7.53M+18.3%-9.22M+59.0%
FX effect on cash129M+1204.3%-11.7M-206.3%11.0M+203.7%-10.6M-953.8%-1.01M-129.2%
Net change in cash1.50B-8.4%1.64B+20.8%1.35B+260.5%376M+122.4%-1.67B-202.4%
Interest paid580M-2.3%593M-5.7%629M+18.2%532M+7.9%493M-3.1%
Income taxes paid22.8M+170.5%8.41M+9.5%7.68M+123.6%3.44M+171.4%-4.81M-135.2%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap129B+61.5%80.1B+65.7%48.3B+56.0%31.0B-19.3%38.4B+42.2%
P/E138.0×+64.0%84.1×-56.1%191.4×+25.8%152.1×+33.3%114.1×+314.1%
P/S11.9×+19.1%10.0×+32.8%7.5×+37.6%5.5×-32.2%8.1×+38.1%
P/B3.1×+22.5%2.5×+19.0%2.1×+30.3%1.6×-25.7%2.2×+28.8%
P/FCF70.6×+23.3%57.2×+17.3%48.8×+45.9%33.5×-13.4%38.6×+60.4%
Earnings yield0.72%-39.0%1.2%+127.5%0.52%-20.5%0.66%-25.0%0.88%-75.9%
FCF yield1.4%-18.9%1.7%-14.8%2.0%-31.4%3.0%+15.5%2.6%-37.7%
Dividend yield1.5%-25.2%2.0%-24.9%2.7%-27.3%3.7%+30.8%2.8%-31.9%
Source filing10-K10-K10-K10-K10-K
Fiscal yearCEOTotal, as reportedActually paidOther executives, average$100 in the stock$100 in peers
FY2025Shankh Mitra$821.1M$999.6M$136.6M$328.20$137.83
FY2024Shankh Mitra$20.2M$106.6M$5.8M$219.00$133.97
FY2023Shankh Mitra$17.3M$40.8M$5M$153.10$123.21
FY2022Shankh Mitra$14.3M$6M$4.1M$108.00$108.34
FY2021Shankh Mitra$12.8M$22.9M$3.1M$137.00$143.30
FY2020Thomas J. DeRosa$9.6M$5.3M$2.6M——

From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.

About this data

Source: WELL’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all WELL filings on SEC EDGAR → Not investment advice.